EGFR and Atrophy: Moreover, it raises the possibility that EGFR blockade will have some therapeutic value in COPD patients with a low quadriceps ST fiber proportion, where this is associated with exercise limitation and mortality and may also predispose patients to muscle wasting as FT fibers are more prone to COPD-related atrophy than ST fibers5,31.